Loading...
Market
First Sector to Report Breakthrough Using OpenCRISPR-1
4
Resolution / Starting Odds
Agriculture • 25%
Biomedicine • 25%
Veterinary • 25%
Biotechnology research • 25%
Scientific journals, industry news updates
Story
ProfluentBio Launches OpenCRISPR-1, First AI-Designed Open-Source Gene Editor
Apr 23, 2024, 01:49 AM
ProfluentBio has announced the successful deployment of the first ever AI-designed gene editor, OpenCRISPR-1, marking a significant advancement in genetic engineering. This innovative tool, developed using ProfluentBio's large language models, consists of a Cas9-like protein and guide RNA. The company has decided to freely release the molecules under the OpenCRISPR initiative, aiming to democratize access to cutting-edge gene editing capabilities and accelerate the development of personalized medicine. The release of OpenCRISPR-1 is expected to revolutionize the field of biomedicine by enabling more widespread and ethical use of CRISPR technologies. Coverage of this development has been provided by @nytimes, with further details available in an article by @cademetz.
View original story
Similar markets
Therapeutic applications • 25%
Research tools • 25%
Diagnostic tools • 25%
Personalized medicine • 25%
North America • 25%
Europe • 25%
Asia-Pacific • 25%
Rest of World • 25%
Pharmaceuticals • 33%
Biotechnology • 33%
Academic Research • 34%
No breakthrough • 33%
Breakthrough in biopharmaceuticals • 33%
Breakthrough in a different field • 34%
Breakthrough findings • 33%
Incremental findings • 33%
Inconclusive results • 34%
Discovery of a new CRISPR enzyme • 33%
Successful editing of a complex genetic condition in vitro • 33%
Patenting a novel delivery mechanism • 34%
Google • 25%
Microsoft • 25%
OpenAI • 25%
Anthropic • 25%
Automotive • 25%
Healthcare • 25%
Manufacturing • 25%
Agriculture • 25%